Home
Membership
Get Involved
Conferences
Education
Public Affairs
Publications
Grants
Awards
About Us
Vacancies

Bookmark and Share

Revolutionizing drug discovery with stem cell technology

18—19 January 2010

GlaxoSmithKline, Stevenage, UK



Organizers:
Aaron Chuang (GlaxoSmithKline, USA)
Melanie Welham (University of Bath, UK)
Katy Gearing (GlaxoSmithKline, UK)

Session 1

 

Chair:
Jason Gardner (GSK, UK)
Monday 18 January 2010
09:30 - 11:00 Registration with tea and coffee

11:00 - 11:10
Welcome
11:10 - 12:00
The ground state of pluripotency
Austin Smith (University of Cambridge, UK)
12:00 - 12:40
Therapeutic and research potential of human stem cells
Stephen Minger (GE Healthcare, UK)
12:40 - 13:00
Surface chemical gradients direct the differentiation of kidney stem cells to proximal tubule cells and podocytes
Selected oral communication - Patricia Murray (University of Liverpool, UK)
13:00 - 14:00 Lunch

Session 2

 

Chair:
Melanie Welham (Univeristy of Bath, UK)
Monday 18 January 2010
14:00 - 14:40
A bio-active polymer promotes stem cell derived hepatocyte inducible drug metabolism
David Hay (Scottish Centre for Regenerative Medicine, UK)
14:40 - 15:20
Derivation and utility of cardiomyocytes from human pluripotent stem cells
Chris Denning (University of Nottingham, UK)
15:20 - 15:50 Coffee/tea break

15:50 - 17:20
Finding new solutions to old problems in drug discovery: Can stem cell technologies help and how?
Round table discussion (Julie Holder, Paul Duffy, Julie Kerby)
17:30 - 18:30 Poster session and drinks reception

18:45 Buses to conference dinner

Session 3

 

Chair:
Graeme Milligan (University of Glasgow, UK)
Tuesday 19 January 2010
09:00 - 09:40
High content screening using human embryonic stem (ES) cell lines
Peter Andrews (University of Sheffield, UK)
09:40 - 10:20
3D tissue culture systems for drug development applications
Lars Sundstrom (University of Southampton, UK)
10:20 - 10:40
Live image based screen on glioblastoma stem cells
Selected oral communication - Davide Danovi (University of Cambridge, UK)
10:40 - 11:10 Coffee/tea break

Session 4

 

Chair:
Peter Andrews (University of Sheffield, UK)
Tuesday 19 January 2010
11:10 - 11:50
Pluripotent stem cells for drug discovery and predictive toxicology
Marc Peschanski (I-Stem, France)
11:50 - 12:30
Identification and characterization of small molecule ligands that maintain pluripotency of hESCs
Graeme Milligan (University of Glasgow, UK)
12:30 - 13:30 Lunch

Session 5

 

Chair:
Aaron Chuang (GSK, USA)
Tuesday 19 January 2010
13:30 - 13:50
Platform technology for three-dimensional cell culture enabling enhanced cell growth, differentiation and function
Selected oral communication - Dan Maltman and Eleanor Knight (Durham University, UK)
13:50 - 14:30
Automation-amenable human pluripotent stem cell culture
Lorraine Young (University of Nottingham, UK)
14:30 - 15:20
Stem cells and drug discovery
Ian Wilmut (Scottish Centre for Regenerative Medicine, UK)
15:20 - 15:30
Presentation of the poster prize and closing remarks with Melanie Welham
15:30 Close of meeting